Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $42.1000 (3.95%) ($41.1000 - $44.7000) on Thu. Oct. 1, 2015. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.12% (three month average) | RSI | 57 | Latest Price | $42.1000(3.95%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -1.5% a day on average for past five trading days. | Weekly Trend | CAPR declines -1.8% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) SKYY(8%) XLF(7%) EWG(6%) EWI(6%) IVE(6%) | Factors Impacting CAPR price | CAPR will decline at least -2.06% in a week (0% probabilities). VIXM(-5%) TLT(-5%) SLV(-3%) GLD(-3%) BND(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.06% (StdDev 4.12%) | Hourly BBV | 0 () | Intraday Trend | -5.8% | | | |
|
Resistance Level | $42.38 | 5 Day Moving Average | $40.38(4.26%) | 10 Day Moving Average | $42.76(-1.54%) | 20 Day Moving Average | $42.38(-0.66%) | To recent high | -17.5% | To recent low | 9.1% | Market Cap | $829m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |